Covered recipient · General Payments record
RAJAKUMAR THOTAKURA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2023
$3,266.36
- Reported across 142 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $350.60 | 18 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $162.06 | 12 |
| Otsuka America Pharmaceutical, Inc. | $145.63 | 4 |
| ITI, Inc. | $42.91 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $10.34 | 01/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999260261 | CMS |
| AbbVie Inc. | $10.15 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999260265 | CMS |
| AbbVie Inc. | $8.01 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999260269 | CMS |
| AbbVie Inc. | $12.04 | 03/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999260273 | CMS |
| AbbVie Inc. | $15.71 | 03/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999260277 | CMS |
| AbbVie Inc. | $21.42 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999260281 | CMS |
| AbbVie Inc. | $26.32 | 06/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999260285 | CMS |
| AbbVie Inc. | $12.95 | 06/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999260289 | CMS |
| AbbVie Inc. | $13.88 | 07/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999260293 | CMS |
| AbbVie Inc. | $6.54 | 07/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999260297 | CMS |
| AbbVie Inc. | $16.96 | 08/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999260301 | CMS |
| AbbVie Inc. | $7.74 | 10/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 999260305 | CMS |
| ITI, Inc. | $18.71 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040722047 | CMS |
| ITI, Inc. | $24.20 | 04/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040722055 | CMS |
| Otsuka America Pharmaceutical, Inc. | $22.71 | 08/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014869661 | CMS |
| Otsuka America Pharmaceutical, Inc. | $10.92 | 09/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014869669 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.17 | 10/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014869677 | CMS |
| Otsuka America Pharmaceutical, Inc. | $91.83 | 10/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014869685 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.